Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-11 · accession 0001714899-24-000219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-13 | 2024-11-11 | DNLI | Schenkein David P | Dir | M - OptEx | $18.00 | +47.2K | 68.7K | +219% | +$849.0K |
| DM | 2024-11-13 | 2024-11-11 | DNLI | Schenkein David P | Dir | S - Sale+OE | $32.51 | -59.4K | 9,220 | -87% | -$1.93M |
| D | 2024-11-13 | 2024-11-11 | DNLI | Schenkein David P | Dir | M - OptEx | $0.00 | -47.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-11 | M | A | 47,165 | $18.00 | 68,661 | D | — | — | (F1) Includes 5,967 Unvested RSUs. |
| 2 | Common | Common Stock | 2024-11-11 | S | D | 27,129 | $32.09 | 41,532 | D | — | — | (F3) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $31.54 to $32.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F1) Includes 5,967 Unvested RSUs. |
| 3 | Common | Common Stock | 2024-11-11 | S | D | 32,312 | $32.87 | 9,220 | D | — | — | (F4) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $32.54 to $33.28 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F1) Includes 5,967 Unvested RSUs. |
| 4 | Derivative | Stock Option (right to buy) | 2024-11-11 | M | D | 47,165 | $0.00 | 0 | D | $18.00 · — to 2027-12-06 | 47,165 Common Stock | (F7) 25% of the shares subject to the option shall vest on December 7, 2018 and an additional 1/48 of the shares vest monthly thereafter. |